Skip to main content

COPD

This study is currently active

This study is for an  inhaled nebulized combination (FDC) suspension as a novel therapy for the maintenance treatment

of chronic obstructive pulmonary disease (COPD). Study will last approximately  one month long with 7 office visits to the clinic. Pulmonary function tests will be required. Medication will be provided as well as rescue albuterol.

Compensation provided up to $1800 for completing all the required visits.

Participate in a Study

Submit the form and a clinical study expert will get in touch with you.

Want to know more about our clinical trials?